Radiopharmaceuticals continue to see increasing levels of activity by nearly every measure. In 2019 there were as many deals, agreements, and approvals as in the previous 3 years combined, and we at The Bracken Group predicted that the growth would only pick up steam in 2020. That is, in fact, what happened: The industry topped the 2019 high water mark by 50%.
What will 2021 bring? Stay tuned. The Bracken Group continues to work in and monitor this developing field.